These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The role of HDL and its modulators in the development of diabetes. Ng DS; Saw NM Curr Opin Lipidol; 2012 Apr; 23(2):167-8. PubMed ID: 22418575 [No Abstract] [Full Text] [Related]
5. Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genes. Fournier N; Atger V; Paul JP; de la Llera Moya M; Rothblat G; Moatti N Atherosclerosis; 1999 Dec; 147(2):227-35. PubMed ID: 10559507 [TBL] [Abstract][Full Text] [Related]
6. Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT. Kypreos KE; Zannis VI Biochem J; 2007 Apr; 403(2):359-67. PubMed ID: 17206937 [TBL] [Abstract][Full Text] [Related]
7. The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice. Holvoet P; De Geest B; Van Linthout S; Lox M; Danloy S; Raes K; Collen D Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):459-66. PubMed ID: 10669644 [TBL] [Abstract][Full Text] [Related]
8. In vivo studies of HDL assembly and metabolism using adenovirus-mediated transfer of ApoA-I mutants in ApoA-I-deficient mice. Reardon CA; Kan HY; Cabana V; Blachowicz L; Lukens JR; Wu Q; Liadaki K; Getz GS; Zannis VI Biochemistry; 2001 Nov; 40(45):13670-80. PubMed ID: 11695916 [TBL] [Abstract][Full Text] [Related]
9. Haptoglobin binding to apolipoprotein A-I prevents damage from hydroxyl radicals on its stimulatory activity of the enzyme lecithin-cholesterol acyl-transferase. Salvatore A; Cigliano L; Bucci EM; Corpillo D; Velasco S; Carlucci A; Pedone C; Abrescia P Biochemistry; 2007 Oct; 46(39):11158-68. PubMed ID: 17824618 [TBL] [Abstract][Full Text] [Related]
11. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT. Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726 [TBL] [Abstract][Full Text] [Related]
13. High density lipoproteins and coronary heart disease. Future prospects in gene therapy. Fruchart JC; Duriez P Biochimie; 1998 Feb; 80(2):167-72. PubMed ID: 9587674 [TBL] [Abstract][Full Text] [Related]
14. In vitro glycation of human apolipoprotein AI reduces its efficiency in lecithin:cholesterol acyltransferase activation. Gugliucci A; Stahl AJ Clin Chim Acta; 1991 Dec; 204(1-3):37-42. PubMed ID: 1819472 [No Abstract] [Full Text] [Related]
15. Activation of lecithin cholesterol acyltransferase by a disulfide-linked apolipoprotein A-I dimer. Calabresi L; Franceschini G; Burkybile A; Jonas A Biochem Biophys Res Commun; 1997 Mar; 232(2):345-9. PubMed ID: 9125178 [TBL] [Abstract][Full Text] [Related]